PRICE T ROWE ASSOCIATES INC /MD/ - AERIE PHARMACEUTICALS INC ownership

AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 132 filers reported holding AERIE PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of AERIE PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$428,000
+262.7%
28,234
+79.7%
0.00%
Q2 2022$118,000
+12.4%
15,715
+36.5%
0.00%
Q1 2022$105,000
+11.7%
11,512
-14.1%
0.00%
Q4 2021$94,000
-71.7%
13,404
-53.9%
0.00%
Q3 2021$332,000
-29.2%
29,104
-0.7%
0.00%
Q2 2021$469,000
-6.4%
29,305
+4.5%
0.00%
Q1 2021$501,000
+32.5%
28,053
+0.2%
0.00%
Q4 2020$378,000
+35.0%
28,001
+17.6%
0.00%
Q3 2020$280,000
-36.5%
23,811
-20.2%
0.00%
Q2 2020$441,000
+21.5%
29,852
+11.1%
0.00%
Q1 2020$363,000
-95.7%
26,864
-92.4%
0.00%
-100.0%
Q4 2019$8,492,000
+22.3%
351,353
-2.7%
0.00%0.0%
Q3 2019$6,942,000
-35.6%
361,167
-1.1%
0.00%
-50.0%
Q2 2019$10,787,000
-37.8%
365,043
+0.0%
0.00%
-33.3%
Q1 2019$17,338,000
+30.8%
365,018
-0.6%
0.00%
+50.0%
Q4 2018$13,254,000
-41.2%
367,140
+0.2%
0.00%
-33.3%
Q3 2018$22,547,000
-7.4%
366,320
+1.7%
0.00%
-25.0%
Q2 2018$24,341,000
+31.3%
360,346
+5.5%
0.00%
+33.3%
Q1 2018$18,533,000
-5.3%
341,619
+4.3%
0.00%0.0%
Q4 2017$19,578,000
+47.4%
327,671
+19.9%
0.00%
+50.0%
Q3 2017$13,286,000
+9.3%
273,373
+18.1%
0.00%0.0%
Q2 2017$12,160,000
-38.9%
231,402
-47.3%
0.00%
-50.0%
Q1 2017$19,908,000
+1873.0%
438,979
+1546.0%
0.00%
Q4 2016$1,009,000
+0.3%
26,670
+0.0%
0.00%
Q3 2016$1,006,000
-90.3%
26,660
-94.7%
0.00%
-100.0%
Q3 2014$10,391,000502,2240.00%
Other shareholders

There were no reported owners of AERIE PHARMACEUTICALS INC in Q4 2021.

NameSharesValueWeighting ↓
View complete list of AERIE PHARMACEUTICALS INC shareholders